ADAR1 Capital Management »

Reviva Pharmaceutcls Hldgs I shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Reviva Pharmaceutcls Hldgs I (RVPH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Reviva Pharmaceutcls Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceutcls Hldgs I held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceutcls Hldgs I by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 2.5k 5.15

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Reviva Pharmaceutcls Hldgs I

Vanguard Group
Millennium Management
Susquehanna International
Citadel Advisors
Polar Securities
EMC Capital Management
Colony
Caption Management
BlackRock
Man Group
Two Sigma Investments
Marshall Wace
Jpmorgan Chase & Co
Jane Street
Virtu Financial

View all funds holding Reviva Pharmaceutcls Hldgs I